Remdesivir
India gives 3,000 vials of Remdesivir to 'friendly' Myanmar to help fight COVID-19
General Naravane and Shringla's two-day visit to Myanmar assumes significance as it comes in the midst of the India-China standoff
US hospitals turn down remdesivir, limit use to severely ill since July
The slowdown suggests that a shortage of the drug is over and threatens Gilead’s efforts to expand use of remdesivir
Dr. Reddy’s releases COVID drug Remdesivir under brand name Redyx
"Dr Reddy's Redyx is available in strength of 100 mg vial," it said
India's cheapest remdesivir version launched by Zydus Cadila at Rs 2,800 per vial
The drug will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients
Maharashtra FDA to buy remdesivir from Gujarat firm
State FDA minister Rajendra Shingne said the government plans to publish the price and availability of the drugs online for transparency
Jubilant Generics gets DCGI nod to manufacture COVID-19 drug Remdesivir
On June 21, Hetero and Cipla and on July 2 Mylan were given permission to manufacture and market the drug on the same conditions
Seven held for selling Remdesivir injections at higher cost
The officials said that each vial of the injection was being sold at 30,000 instead of 4,500
Gilead starts testing inhaled version of remdesivir for COVID-19
Gilead also plans to start additional clinical trials to evaluate remdesivir when used in combination with anti-inflammatory medicines
Mylan Pharma to launch remdesivir in India at Rs 4,800 per 100 mg vial
The drug will be launched under the brand name Desrem in India and will be available to patients later this month
Remdesivir gets conditional EU clearance to be used in severe COVID-19 patients
The move comes just days after Gilead allocated nearly all of its supply of remdesivir for the next three months to the US